
    
      ivermectin was used in Egypt during the pandemic of covid-19 and it was registered in the MOH
      protocol that has been published in November 2020 the study will document the adverse effects
      of many patients used ivermectin as aprophylaxis and as a treatment with multiple dose
      regimens
    
  